{"doc_id": "33419674", "type of study": "Therapy", "title": "", "abstract": "Effects and safety of herbal medicines among community-dwelling residents during COVID-19 pandemic: A large prospective, randomized controlled trial (RCT).\nSince the declaration of COVID-19 as a global pandemic by the World Health Organization, countries are struggling with a shortage of medical capacities.\nIt would be essential if the risk for preventable comorbidities, such as the common cold, can be reduced or prevented, so that the scarce medical resources and facilities can be focused on COVID-19.\nTo evaluate the effects of two herbal medicines (Jinhaoartemisia antipyretic granules and Huoxiangzhengqi oral liquids) in reducing the risk of the common cold in community-dwelling residents in China during the COVID-19 outbreak.\nSTUDY DESIGN : A prospective open-label, parallel-group, cluster-randomized controlled trial (RCT), was conducted in Chengdu, China.\nA total of 22,065 participants from 11 communities were recruited during a period of one month.\nThe trial started on 30 January and participants were followed up till 29 February 2020.\nParticipants were randomly assigned to receive either a five-day herbal medicine therapy plus a reference manual or a reference manual only if they were allocated to the control group.\nThe primary endpoint was the occurrence of patient-reported common cold symptoms.\nThe secondary endpoint was the time in days from the receipt of herbal drugs/reference manual and the occurrence of the common cold symptoms.\nUse of herbal medicine reduced the risk of the common cold by 89.6% (95% CI, 52.9% to 97.7%) in all community-dwelling residents, and by 94.0% (95% CI, 52.1% to 99.2%) in residents aged between 16 and 59 years old.\nSensitivity analyses showed similar results.\nThis community-based RCT found that the use of a herbal medicine therapy (Jinhaoartemisia antipyretic granules and Huoxiangzhengqi oral liquids) could significantly reduce the risks of the common cold among community-dwelling residents, suggesting that herbal medicine may be a useful approach for public health intervention to minimize preventable morbidity during COVID-19 outbreak.\nCopyright \u00a9 2020 Elsevier GmbH. All rights reserved.\n", "Evidence Map": {"Enrollment": [{"term": "community-dwelling residents", "negation": "affirmed", "UMLS": {}, "start": 45, "end": 73}, {"term": "COVID-19 pandemic", "negation": "affirmed", "UMLS": {}, "start": 81, "end": 98}, {"term": "community-dwelling residents", "negation": "affirmed", "UMLS": {}, "start": 165, "end": 193}, {"term": "community-dwelling", "negation": "affirmed", "UMLS": {}, "start": 107, "end": 125}, {"term": "community-dwelling", "negation": "affirmed", "UMLS": {}, "start": 209, "end": 227}], "Comparison Results": [], "Study Arm 1 Results": [], "Study Arm 2 Results": [], "Hypothesis": []}, "Sentence-level breakdown": [{"Section": "TITLE", "Text": "Effects and safety of herbal medicines among community-dwelling residents during COVID-19 pandemic : A large prospective , randomized controlled trial ( RCT ) .", "Evidence Elements": {"Participant": [{"term": "community-dwelling residents", "negation": "affirmed", "UMLS": {}, "start": 45, "end": 73}, {"term": "COVID-19 pandemic", "negation": "affirmed", "UMLS": {}, "start": 81, "end": 98}], "Intervention": [{"term": "herbal medicines", "negation": "affirmed", "UMLS": {}, "start": 22, "end": 38}], "Outcome": [{"term": "Effects", "negation": "affirmed", "UMLS": {}, "start": 0, "end": 7}, {"term": "safety", "negation": "affirmed", "UMLS": {}, "start": 12, "end": 18}], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "BACKGROUND", "Text": "Since the declaration of COVID-19 as a global pandemic by the World Health Organization , countries are struggling with a shortage of medical capacities .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "BACKGROUND", "Text": "It would be essential if the risk for preventable comorbidities , such as the common cold , can be reduced or prevented , so that the scarce medical resources and facilities can be focused on COVID-19 .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "PURPOSE", "Text": "To evaluate the effects of two herbal medicines ( Jinhaoartemisia antipyretic granules and Huoxiangzhengqi oral liquids ) in reducing the risk of the common cold in community-dwelling residents in China during the COVID-19 outbreak .", "Evidence Elements": {"Participant": [{"term": "community-dwelling residents", "negation": "affirmed", "UMLS": {}, "start": 165, "end": 193}], "Intervention": [{"term": "herbal medicines", "negation": "affirmed", "UMLS": {}, "start": 31, "end": 47}, {"term": "Jinhaoartemisia antipyretic granules", "negation": "affirmed", "UMLS": {}, "start": 50, "end": 86}, {"term": "Huoxiangzhengqi oral liquids", "negation": "affirmed", "UMLS": {}, "start": 91, "end": 119}], "Outcome": [{"term": "risk of the common cold", "negation": "affirmed", "UMLS": {}, "start": 138, "end": 161}], "Observation": [{"term": "reducing", "negation": "affirmed", "UMLS": {}, "start": 125, "end": 133}], "Count": []}, "Evidence Propositions": [{"Intervention": "herbal medicines", "Observation": "reducing", "Outcome": "risk of the common cold", "Count": ""}, {"Intervention": "Jinhaoartemisia antipyretic granules", "Observation": "reducing", "Outcome": "risk of the common cold", "Count": ""}, {"Intervention": "Huoxiangzhengqi oral liquids", "Observation": "reducing", "Outcome": "risk of the common cold", "Count": ""}]}, {"Section": "UNKNOWN", "Text": "STUDY DESIGN : A prospective open-label , parallel-group , cluster-randomized controlled trial ( RCT ) , was conducted in Chengdu , China .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "METHODS", "Text": "A total of 22,065 participants from 11 communities were recruited during a period of one month .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "METHODS", "Text": "The trial started on 30 January and participants were followed up till 29 February 2020 .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "METHODS", "Text": "Participants were randomly assigned to receive either a five-day herbal medicine therapy plus a reference manual or a reference manual only if they were allocated to the control group .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "five-day herbal medicine therapy plus a reference manual", "negation": "affirmed", "UMLS": {}, "start": 56, "end": 112}, {"term": "reference manual", "negation": "affirmed", "UMLS": {}, "start": 96, "end": 112}, {"term": "control", "negation": "affirmed", "UMLS": {}, "start": 170, "end": 177}], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "METHODS", "Text": "The primary endpoint was the occurrence of patient-reported common cold symptoms .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [{"term": "occurrence of patient-reported common cold symptoms", "negation": "affirmed", "UMLS": {}, "start": 29, "end": 80}], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "METHODS", "Text": "The secondary endpoint was the time in days from the receipt of herbal drugs / reference manual and the occurrence of the common cold symptoms .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [{"term": "time in days from the receipt of", "negation": "affirmed", "UMLS": {}, "start": 31, "end": 63}, {"term": "reference manual", "negation": "affirmed", "UMLS": {}, "start": 79, "end": 95}, {"term": "occurrence of the common cold symptoms", "negation": "affirmed", "UMLS": {}, "start": 104, "end": 142}], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "RESULTS", "Text": "Use of herbal medicine reduced the risk of the common cold by 89.6 % ( 95 % CI , 52.9 % to 97.7 % ) in all community-dwelling residents , and by 94.0 % ( 95 % CI , 52.1 % to 99.2 % ) in residents aged between 16 and 59 years old .", "Evidence Elements": {"Participant": [{"term": "community-dwelling", "negation": "affirmed", "UMLS": {}, "start": 107, "end": 125}], "Intervention": [{"term": "herbal medicine", "negation": "affirmed", "UMLS": {}, "start": 7, "end": 22}], "Outcome": [{"term": "risk of the common cold", "negation": "affirmed", "UMLS": {}, "start": 35, "end": 58}], "Observation": [{"term": "reduced", "negation": "affirmed", "UMLS": {}, "start": 23, "end": 30}, {"term": "89.6 %", "negation": "affirmed", "UMLS": {}, "start": 62, "end": 68}, {"term": "94.0 %", "negation": "affirmed", "UMLS": {}, "start": 145, "end": 151}], "Count": []}, "Evidence Propositions": []}, {"Section": "RESULTS", "Text": "Sensitivity analyses showed similar results .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "CONCLUSION", "Text": "This community-based RCT found that the use of a herbal medicine therapy ( Jinhaoartemisia antipyretic granules and Huoxiangzhengqi oral liquids ) could significantly reduce the risks of the common cold among community-dwelling residents , suggesting that herbal medicine may be a useful approach for public health intervention to minimize preventable morbidity during COVID-19 outbreak .", "Evidence Elements": {"Participant": [{"term": "community-dwelling", "negation": "affirmed", "UMLS": {}, "start": 209, "end": 227}], "Intervention": [{"term": "herbal medicine therapy", "negation": "affirmed", "UMLS": {}, "start": 49, "end": 72}, {"term": "antipyretic granules", "negation": "affirmed", "UMLS": {}, "start": 91, "end": 111}, {"term": "Huoxiangzhengqi oral liquids", "negation": "affirmed", "UMLS": {}, "start": 116, "end": 144}, {"term": "herbal medicine", "negation": "affirmed", "UMLS": {}, "start": 49, "end": 64}], "Outcome": [{"term": "risks of the common cold", "negation": "affirmed", "UMLS": {}, "start": 178, "end": 202}], "Observation": [{"term": "significantly reduce", "negation": "affirmed", "UMLS": {}, "start": 153, "end": 173}, {"term": "useful", "negation": "affirmed", "UMLS": {}, "start": 281, "end": 287}], "Count": []}, "Evidence Propositions": [{"Intervention": "herbal medicine therapy", "Observation": "significantly reduce", "Outcome": "risks of the common cold", "Count": ""}, {"Intervention": "antipyretic granules", "Observation": "significantly reduce", "Outcome": "risks of the common cold", "Count": ""}, {"Intervention": "Huoxiangzhengqi oral liquids", "Observation": "significantly reduce", "Outcome": "risks of the common cold", "Count": ""}]}, {"Section": "UNKNOWN", "Text": "Copyright \u00a9 2020 Elsevier GmbH . All rights reserved .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}]}